Get Full access to Top 1000 data, subscribe from only €29

AMCo Ireland

Add to comparison

AMCo is the result of a merger of Amdipharm and the Mercury Pharma Group in 2013, and is an emerging pharmaceutical enterprise comprising a series of companies operating internationally. Amdipharm was formed in 2002 and specialises in marketing internationally branded products to primary and secondary care prescribers. Since 2002 and through twelve acquisitions, Amdipharm now offers 35 products which sell in over 100 countries across the world.

Financial Data

31st Dec 18 Source: CRO
- €221.3 million turnover
- €5 million profit
- 14 employees
- Auditor: PwC
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 17 Source: CRO
- €255.3 million turnover
- €6.5 million profit
- 15 employees
- Auditor: PwC
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
7 more years available »